Cargando…

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis

SIMPLE SUMMARY: Several factors are known to affect colorectal cancer (CRC) patient survival, including elevated platelet counts (thrombocytosis) and chromogranin A-positive neuroendocrine-cell differentiation (CgA(+)). Thrombocytosis can occur due to biochemical changes caused by the tumor itself (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herold, Zoltan, Dank, Magdolna, Herold, Magdolna, Nagy, Peter, Rosta, Klara, Somogyi, Aniko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796394/ https://www.ncbi.nlm.nih.gov/pubmed/33383764 http://dx.doi.org/10.3390/cancers13010067

Ejemplares similares

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
por: Herczeg, Gyorgy, et al.
Publicado: (2022)

Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
por: Herold, Zoltan, et al.
Publicado: (2020)

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis
por: Herold, Zoltan, et al.
Publicado: (2020)

Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
por: Dank, Magdolna, et al.
Publicado: (2022)

Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
por: Herold, Magdolna, et al.
Publicado: (2023)

New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
por: Nagy, Geza, et al.
Publicado: (2022)

Longitudinal Analysis of 1α,25-dihidroxyvitamin D(3) and Homocysteine Changes in Colorectal Cancer
por: Mühl, Dorottya, et al.
Publicado: (2022)

Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
por: Herold, Zoltan, et al.
Publicado: (2021)

Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients
por: Elek, Zsuzsanna, et al.
Publicado: (2020)

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
por: Szasz, Attila Marcell, et al.
Publicado: (2023)

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
por: Kleef, Ralf, et al.
Publicado: (2023)

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
por: Petenyi, Flora Greta, et al.
Publicado: (2021)

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer
por: Barna, Andras Jozsef, et al.
Publicado: (2023)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

Pravastatin in preeclampsia: A meta-analysis and systematic review
por: Mészáros, Balázs, et al.
Publicado: (2023)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
por: Ágoston, Emese Irma, et al.
Publicado: (2022)

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
por: Dank, Magdolna, et al.
Publicado: (2023)

Role and function of granin proteins in diabetes mellitus
por: Herold, Zoltan, et al.
Publicado: (2021)

Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line
por: Kiss, Eva, et al.
Publicado: (2022)

Changes in the cochlear and retrocochlear parts of the auditory system in 19–39 and 40–60 years old patients with type 1 diabetes mellitus
por: Horváth, Mihály, et al.
Publicado: (2023)

Quantitative PCR from human genomic DNA: The determination of gene copy numbers for congenital adrenal hyperplasia and RCCX copy number variation
por: Doleschall, Márton, et al.
Publicado: (2022)

A Liquid Biopsy-Based Approach for Monitoring Treatment Response in Post-Operative Colorectal Cancer Patients
por: Barták, Barbara Kinga, et al.
Publicado: (2022)

Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines
por: Kiss, Eva, et al.
Publicado: (2021)

The Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary
por: Kiss, Eva, et al.
Publicado: (2022)

Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus
por: Firneisz, Gábor, et al.
Publicado: (2020)

Comments on: A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus
por: Rosta, Klara, et al.
Publicado: (2020)

Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
por: Szasz, Attila M., et al.
Publicado: (2019)

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
por: Kajáry, Kornélia, et al.
Publicado: (2019)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case–control study
por: Rosta, Klara, et al.
Publicado: (2018)

Vaginal Progesterone Has No Diabetogenic Potential in Twin Pregnancies: A Retrospective Case-Control Study on 1686 Pregnancies
por: Rosta, Klara, et al.
Publicado: (2020)

Right-Sided clinical findings are worse prognostic factor in Multiple Sclerosis patients?
por: Varoglu, Asuman O., et al.
Publicado: (2020)

What to expect from drug targeting factor XI?
por: Nagy, Magdolna, et al.
Publicado: (2022)

Chromogranin A Tubulopathy: Differing Histopathologic Patterns of Acute Tubular Injury in the Setting of Neuroendocrine Neoplasms
por: Sekulic, Miroslav, et al.
Publicado: (2019)

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
por: Abdou, Yara, et al.
Publicado: (2022)

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study
por: Tőkés, Tímea, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8s8cc7mdib2mlj07qmdoh4gvnp